Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (SCBs) can result in anxiety, psychosis, chest pain, seizures and death. To potentially explain higher toxicity associated with SCB use, we hypothesized that AB-PINACA, a common second generation SCB, exhibits atypical pharmacodynamic properties at CB1 cannabinoid receptors (CB1Rs) and/or a distinct metabolic profile when compared to Δ9-tetrahydrocannabinol (Δ9-THC), the principal psychoactive cannabinoid present in marijuana. Liquid chromatography tandem mass spectrometry (LC/MS) identified AB-PINACA and monohydroxy metabolite(s) as primary phase I metabolites (4OH-AB-PINACA and/or 5OH-AB-PINACA) in human urine and serum obtained from ...
CP47,497 and other synthetic cannabinoid compounds were incipiently synthesized as research tools to...
Research evidence suggests a dose-response relationship for the association between cannabis use and...
Synthetic cannabinoids (SCs) represented 45% of new psychoactive substances seizures in Europe (data...
Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabi...
Synthetic cannabinoids (SCs) are the largest group of compounds currently monitored in Europe by the...
K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often as...
5F-MDMB-PINACA and 4F-MDMB-BINACA are synthetic cannabinoids (SCs) that elicit cannabinoid psychoact...
Since the early 2000s, herbal mixtures containing synthetic cannabinoids (SCs), broadly known as Spi...
The chief psychoactive constituent of many bioactive phytocannabinoids (D9-tetrahydrocannabinol, D9-...
K2 and several similar purported “incense products” spiked with synthetic cannabinoids are abused as...
(-)-Trans-Δ9-tetrahydrocannabinol (Δ9-THC) is the main compound responsible for the intoxicant activ...
Synthetic cannabinoid receptor agonists (SCRAs) remain popular drugs of abuse. As many SCRAs are kno...
A new class of synthetic cannabinoids has emerged as new psychoactive substances (NPS). Similar in s...
Synthetic cannabinoid receptor agonists (SCRAs) are the largest class of new psychoactive substances...
Synthetic cannabinoids receptor agonists (SCRAs) are often almost completely metabolised, and hence ...
CP47,497 and other synthetic cannabinoid compounds were incipiently synthesized as research tools to...
Research evidence suggests a dose-response relationship for the association between cannabis use and...
Synthetic cannabinoids (SCs) represented 45% of new psychoactive substances seizures in Europe (data...
Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabi...
Synthetic cannabinoids (SCs) are the largest group of compounds currently monitored in Europe by the...
K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often as...
5F-MDMB-PINACA and 4F-MDMB-BINACA are synthetic cannabinoids (SCs) that elicit cannabinoid psychoact...
Since the early 2000s, herbal mixtures containing synthetic cannabinoids (SCs), broadly known as Spi...
The chief psychoactive constituent of many bioactive phytocannabinoids (D9-tetrahydrocannabinol, D9-...
K2 and several similar purported “incense products” spiked with synthetic cannabinoids are abused as...
(-)-Trans-Δ9-tetrahydrocannabinol (Δ9-THC) is the main compound responsible for the intoxicant activ...
Synthetic cannabinoid receptor agonists (SCRAs) remain popular drugs of abuse. As many SCRAs are kno...
A new class of synthetic cannabinoids has emerged as new psychoactive substances (NPS). Similar in s...
Synthetic cannabinoid receptor agonists (SCRAs) are the largest class of new psychoactive substances...
Synthetic cannabinoids receptor agonists (SCRAs) are often almost completely metabolised, and hence ...
CP47,497 and other synthetic cannabinoid compounds were incipiently synthesized as research tools to...
Research evidence suggests a dose-response relationship for the association between cannabis use and...
Synthetic cannabinoids (SCs) represented 45% of new psychoactive substances seizures in Europe (data...